Clinical Trials Browser

Phase 1/2 × Recurrence × Drug Therapy × Clear all

NCT06090864 2025-10-20

ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells

Phase 1/2 Recruiting

Hodgkin Disease, Recurrence